Device Trial Radar · NCT07147881
Prospective Real-World Evidence Study of the IpsiHand® System in Adult Stroke Survivors
Last checked: Nov 20, 2026Latest source record: Aug 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Sep 1, 2025
Primary completion
Dec 1, 2027
Study completion Jan 1, 2028
Sponsor
- Lead sponsor
- Neurolutions, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 29, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study focuses on monitoring real-world customers who have been prescribed the IpsiHand® as part of their rehabilitation post-stroke. This study aims to evaluate their progress over time, assessing motor recovery, functional independence in activities of daily living (ADLs), caregiver burden, and health economic outcomes.
Conditions
- Stroke
- Hemiparesis After Stroke
- Brain Computer Interface
Interventions
IpsiHandDevice
IpsiHand is a therapeutic device that uses a brain-computer interface system which detects neural signals associated with motor intent and translates them into assisted hand movements in individuals with upper extremity impairment following a stroke.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Fugl-Meyer - Upper Extremity (FM-UE) , Manual Long FormTime frame: Baseline visit and at 4-week, 8-week, 12-week, 16-week, 20-week, 24-week, 28-week, 32-week, 36-week, 12-months, and 24 months of IpsiHand® device use, or until completion of IpsiHand® device use if occurring prior to 24 months.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.